Nesta página
01ALGN preço
02Instantâneo
03Gráfico
05Sobre
06Desempenho
07Avaliação e rácios
14Lucros
15Fundamentos Completos
16Demonstrações
17Investidores institucionais (13F)
18Ativistas e proprietários de 5%+
19Executivos da empresa
20Participação em ETFs
21Consenso
22Pares
23Notícias
25Sinais de trading
26Minhas Métricas
ALGN Align Technology, Inc. - Common Stock
NASDAQ · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 5, 2026
$143,74
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$124,91mínima 52 sem
$200,44máxima 52 sem
Capitalização de Mercado (MRQ)
$10.24B
P/E (TTM)
25.0
EPS (TTM)
$5.74
Receita (TTM)
$4.14B
seus distintivos
Intervalo 52 Semanas
$125–$200
Classificação do Analista
BUY
Preço-Alvo
$206
P/E
25.0
ROE
10.2%
Margem de Lucro Líquido
10.0%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
ALGN Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$143.74
Capitalização de Mercado (MRQ)
$10.24B
P/E (TTM)
25.0
EPS (TTM)
$5.74
Receita (TTM)
$4.14B
ROE (TTM)
10.2%
Intervalo 52 Semanas
$125–$200
ALGN Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Align Technology, Inc. - Common Stock Visão geral da empresa da Wikipedia
Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.
Invisalign
Invisalign is a brand of clear aligners manufactured by Align Technology. The clear align system had been used to treat more than 18 million patients by 2017, and 22 million patients by 2026.
Align Technology founder Zia Chishti conceived of the basic design of Invisalign while an adult orthodontics patient. During his treatment with a retainer intended to complete his treatment, he posited that a series of such devices could effect a large final placement in a series of small movements. He partnered with Kelsey Wirth to seek developers.
Invisalign was approved by the Food and Drug Administration in 1998, and sales began in the U.S. in 1999. Orthodontists were resistant to adopting Invisalign at first, in particular because the founders had no orthodontic credentials or expertise, but the product became popular among consumers. The company raised about $140 million in funding over four rounds from 1997 to 2000. In 2000 Align Technology planned a $31 million television advertising campaign that The New York Times said would be "the most aggressive consumer advertising plan the dental profession has ever seen". In 2001, $130 million in additional funding was raised through an initial public offering on NASDAQ. By 2001, 75 percent of the 8,500 orthodontists in North America had been trained on the Invisalign system. That same year, Align Technology made Invisalign available to general dentists following a class-action lawsuit that alleged making the system available only to orthodontists resulted in unfair competition for dentists.
In the early 2000s, Align Technology was spending nearly all of its revenues on marketing and advertising, and losing about $18 million per year. Cofounders Wirth and Chishti resigned from Align Technology in 2001 and 2003 respectively, with Thomas Prescott replacing Chishti as CEO in March 2002. Prescott re-focused the company on North America and cut the marketing budget to about one-third its original size.
The Invisalign system grew from 80,000 patients in 2002 to 175,000 in 2004. It won several awards for stereolithography, medical design and fast growth. Align Technology was profitable for the first time in 2003. In 2005 the company expanded into Japan, and acquired General Orthodontic, an orthodontics firm that supported doctors prescribing the Invisalign system. Later that year, the Harvard School of Dental Medicine began requiring that its orthodontic graduate students complete Invisalign certification before they graduate.
The Invisalign Express 10, which uses 10 aligners, was introduced in 2005. Invisalign 1.5 was released in 2009. It was followed by Invisalign G3 in 2010 and G4 in 2011. Invisalign G3 and G4 were designed for more complex treatments. An Invisalign Express 5 version, which uses 5 aligners, was introduced in 2012. In February 2014, Align Technology released a G5 product designed to treat deep bites.
Support, software engineering, pre-production and administrative functions are done from Align Technology's headquarters in California. The manufacturing of Invisalign aligners is performed in Mexico, and treatment plans are created in Costa Rica. Align Technology also operates separate subsidiaries in Hong Kong and Australia that sell Invisalign in their respective markets. Align Technology provides training and certification to doctors.
In 2007 the Academy of General Dentistry approved Align Technology's Program Approval for Continuing Education (PACE) program. The company also created the AlignTech Institute, which provides educational resources to doctors. In March 2011 Align Technology acquired Cadent System, Inc., a dentist firm, for $190 million.
A major revision to the manufacturing process was started in 2026, a switch from mold-based appliance manufacture to 3D-printing, aimed at reducing the cost and complexity of the manufacturing process through disintermediation.
History
Align Technology was founded in 1997 by Zia Chishti and Kelsey Wirth, classmates at Stanford Graduate School of Business, and began working on the development of a clear aligner. Align received FDA clearance to market the Invisalign system in 1998, and it was first marketed in 2000. Align Technology went public on January 26, 2001, on the Nasdaq Stock Market.
In March 2011 Align acquired the Israeli company Cadent for $190 million; Cadent manufactured intraoral scanners that included 3D imaging, as well as software to display the acquired images and to plan treatment.
Joseph M. Hogan joined Align in June 2015, and is CEO and president.
The company's sales reached $1 billion for the first time in 2016 and its products were being used in about 8% of people who got braces. In 2017 the company was faced with the challenge of the expiration of its patents on its Invisalign system starting in October 2017 and the beginning of generic competition.
In March 2020, Align Technology announced that it has signed a definitive agreement to acquire exocad Global Holdings for approximately $418.7 million.
As of February 2023, Align Technology has assisted over 234,000 doctors and over 14.5 million patients worldwide.
In September 2023, it was announced Align Technology had acquired the Vienna-headquartered 3D printing technology and materials company, Cubicure GmbH.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealth Care
indústriaHealth Care
funcionários20.435
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$4.03B2016-12-31 → 2025-12-31
EPS$5.652016-12-31 → 2025-12-31
Fluxo de caixa livre$491M2016-12-31 → 2025-12-31
Margem líquida10.0%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | ALGN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 25.0média 5A ≈45.1 | ≈45.1 | 28.5 | Sobreavaliado | |
| P/S (TTM) | 2.5média 5A ≈5.9 | ≈5.9 | 2.1 | Sobreavaliado | |
| P/B (MRQ) | 2.4média 5A ≈6.2 | ≈6.2 | 2.1 | Sobreavaliado | |
| Preço / FCF (TTM) | 16.2média 5A ≈41.4 | ≈41.4 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 13.6média 5A ≈27.7 | ≈27.7 | 17.6 | Sobreavaliado | |
| Preço / Valor Patrimonial Tangível (MRQ) | 2.5média 5A ≈7.3 | ≈7.3 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | ALGN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 68.0%média 5A ≈70.4% | ≈70.4% | 58.2% | Primeira linha | |
| Margem Operacional (TTM) | 13.2%média 5A ≈17.5% | ≈17.5% | 11.8% | Primeira linha | |
| Margem EBITDA (TTM) | 19.4%média 5A ≈21.3% | ≈21.3% | 17.6% | Em linha | |
| Margem de Impostos Pré-Tributação (TTM) | 13.7%média 5A ≈17.6% | ≈17.6% | 10.1% | Primeira linha | |
| Margem de Lucro Líquido (TTM) | 10.0%média 5A ≈12.3% | ≈12.3% | 6.7% | Primeira linha | |
| ROA (TTM) | 6.5%média 5A ≈8.2% | ≈8.2% | 3.5% | Primeira linha | |
| ROE (TTM) | 10.2%média 5A ≈12.9% | ≈12.9% | 6.5% | Primeira linha | |
| ROIC | 9.4%média 5A ≈12.8% | ≈12.8% | 5.1% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | ALGN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 1.4média 5A ≈1.3 | ≈1.3 | 1.7 | Baixa liquidez | |
| Quick Ratio (Índice de Liquidez Seca) | 1.1média 5A ≈1.0 | ≈1.0 | 0.5 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | ALGN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 0.90%média 5A ≈12.4% | ≈12.4% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 2.6%média 5A ≈6.3% | ≈6.3% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 10.3% | · | · | · | |
| EPS YoY | 0.53%média 5A ≈-17.2% | ≈-17.2% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -2.6%média 5A ≈-18.9% | ≈-18.9% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 7.0%média 5A ≈-15.3% | ≈-15.3% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | -24.1% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 4.3%média 5A ≈-17.0% | ≈-17.0% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -25.4% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | ALGN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.6média 5A ≈0.7 | ≈0.7 | 0.6 | Em linha | |
| Inventory Turnover (Giro de Estoque) | 5.5média 5A ≈4.6 | ≈4.6 | 2.7 | Primeira linha | |
| Receivables Turnover (Giro de Contas a Receber) | 3.8média 5A ≈4.4 | ≈4.4 | 7.7 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$197.5K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
4.2%
Próximo relatório
Out 28, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 29, 2026 | $2.64 | $2.66 | -0.87% |
| 31 de Março de 2026 | $2.58 | $2.33 | 11.0% | |
| 31 de Dezembro de 2025 | $3.29 | $3.03 | 8.5% | |
| 30 de Setembro de 2025 | $2.61 | $2.45 | 6.5% | |
| 30 de Junho de 2025 | $2.49 | $2.62 | -5.0% | |
| 31 de Março de 2025 | $2.13 | $2.02 | 5.2% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Cost of Revenue | $1.32B | $1.20B | $1.16B | $1.10B | $1.02B | $709M | $663M | $519M | $356M | $265M | $205M | $183M | |
| Gross Profit | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B | $1.74B | $1.45B | $1.12B | $815M | $640M | $578M | |
| R&D Expense | $370M | $364M | $347M | $305M | $250M | $175M | $157M | $129M | $98M | $76M | $61M | $53M | |
| SG&A Expense | $1.76B | $1.76B | $1.70B | $1.67B | $1.71B | $1.20B | $1.07B | $852M | · | · | $390M | $332M | |
| Operating Expenses | $2.17B | $2.19B | $2.06B | $1.99B | $1.96B | $1.38B | $1.20B | $981M | $763M | $566M | $451M | $385M | |
| Operating Income | $546M | $608M | $643M | $643M | $976M | $387M | $542M | $467M | $354M | $249M | $189M | $194M | |
| Interest Income | · | · | · | · | · | · | $12M | $9M | $7M | $4M | · | · | |
| Other Non-op | $23M | $-19M | $-19M | $-49M | $33M | $-11M | $8M | $-8M | $4M | $-11M | $-3M | $-3M | |
| Pretax Income | $585M | $609M | $641M | $599M | $1.01B | $379M | $563M | $467M | $365M | $243M | $186M | $190M | |
| Income Tax | $175M | $188M | $196M | $237M | $240M | $-1.40B | $112M | $58M | $130M | $51M | $42M | $45M | |
| Net Income | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| EPS (Basic) | $5.66 | $5.63 | $5.82 | $4.62 | $9.78 | $22.55 | $5.57 | $5.00 | $2.89 | $2.38 | $1.80 | $1.81 | |
| EPS (Diluted) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | |
| Shares (Basic) | 72,542,000 | 74,877,000 | 76,426,000 | 78,190,000 | 78,917,000 | 78,760,000 | 79,424,000 | 80,064,000 | 80,085,000 | 79,856,000 | 79,998,000 | 80,754,000 | |
| Shares (Diluted) | 72,588,000 | 74,993,000 | 76,568,000 | 78,420,000 | 79,670,000 | 79,230,000 | 80,100,000 | 81,357,000 | 81,832,000 | 81,484,000 | 81,521,000 | 82,283,000 | |
| EBITDA | $783M | $753M | $786M | $768M | $1.09B | $481M | $621M | $521M | $391M | $273M | $207M | $211M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.09B | $1.04B | $937M | $942M | $1.10B | $961M | $550M | $637M | $450M | $389M | $168M | $200M | |
| Short-term Investments | · | · | · | · | · | · | $318M | $98M | $272M | $251M | $360M | $255M | |
| Receivables | $1.10B | $996M | $903M | $860M | $897M | $658M | $550M | $439M | $324M | $247M | $159M | $130M | |
| Inventory | $226M | $254M | $297M | $339M | $230M | $139M | $112M | $56M | $32M | $27M | $19M | $16M | |
| Prepaid Expense | $166M | $199M | $274M | $226M | $195M | $92M | $102M | $72M | $81M | $38M | $27M | $20M | |
| Other Current Assets | $47M | $82M | $77M | $17M | $31M | $62M | $24M | $7M | · | · | · | · | |
| Current Assets | $2.62B | $2.49B | $2.45B | $2.42B | $2.49B | $1.85B | $1.63B | $1.30B | $1.16B | $953M | $732M | $657M | |
| PP&E (Net) | $1.13B | $1.27B | $1.29B | $1.23B | $1.08B | $735M | $632M | $521M | $349M | $175M | $136M | $90M | |
| PP&E (Gross) | $1.90B | $1.93B | $1.84B | $1.68B | $1.44B | $1.04B | $861M | $693M | $485M | $311M | $255M | $198M | |
| Accum. Depreciation | $767M | $662M | $551M | $450M | $359M | $301M | $230M | $172M | $136M | $136M | $118M | $108M | |
| Goodwill | $492M | $443M | $420M | $408M | $419M | $445M | $64M | $64M | $65M | $61M | $61M | $61M | |
| Intangibles | $94M | $103M | $82M | $96M | $110M | $130M | $12M | $18M | $24M | $21M | $18M | $21M | |
| Other Non-current Assets | $278M | $234M | $129M | $56M | $58M | $35M | $40M | $27M | $44M | $13M | $8M | $8M | |
| Total Assets | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Accounts Payable | $121M | $109M | $113M | $128M | $164M | $142M | $87M | $64M | $37M | $29M | $34M | $23M | |
| Accrued Liabilities | $537M | $598M | $526M | $454M | $607M | $406M | $320M | $235M | $196M | $134M | $108M | $88M | |
| Current Liabilities | $1.92B | $2.04B | $2.07B | $1.93B | $1.92B | $1.33B | $971M | $692M | $500M | $354M | $272M | $202M | |
| Capital Leases | $83M | $88M | $97M | $100M | $103M | $64M | $43M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $114M | $140M | $173M | $196M | $175M | $100M | $37M | $29M | $16M | $1M | $2M | $3M | |
| Total Liabilities | $2.18B | $2.36B | $2.45B | $2.35B | $2.32B | $1.60B | $1.15B | $800M | $630M | $401M | $311M | $235M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | |
| Paid-in Capital | $1.51B | $1.36B | $1.16B | $1.04B | $999M | $975M | $907M | $878M | $886M | $865M | $822M | $783M | |
| Retained Earnings | $2.46B | $2.48B | $2.45B | $2.57B | $2.62B | $2.22B | $440M | $378M | $267M | $131M | $27M | $-31M | |
| AOCI | $75M | $6M | $21M | $-10M | $4M | $44M | $-688.0K | $-3M | $571.0K | $-938.0K | $-980.0K | $-140.0K | |
| Stockholders' Equity | $4.05B | $3.85B | $3.63B | $3.60B | $3.62B | $3.23B | $1.35B | $1.25B | $1.15B | $999M | $848M | $753M | |
| Liabilities + Equity | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Shares Outstanding | 71,364,000 | 73,849,000 | 75,075,000 | 77,267,000 | 78,710,000 | 78,860,000 | 78,433,000 | 79,778,000 | 80,040,000 | 79,553,000 | 79,500,000 | 80,205,000 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $237M | $145M | $142M | $126M | $109M | $94M | $79M | $55M | $38M | $24M | $18M | $18M | |
| Stock-based Comp | $186M | $174M | $154M | $133M | $114M | $98M | $88M | $71M | $59M | $54M | $53M | $40M | |
| Deferred Tax | $33M | $26M | $-19M | $-39M | $15M | $-1.49B | $307.0K | $-16M | $18M | $-16M | $-11M | $4M | |
| Amort. of Intangibles | $19M | $19M | $16M | $16M | $17M | $13M | $6M | $6M | $6M | $3M | · | · | |
| Restructuring | · | $37M | $14M | $10M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-274M | $-28M | $63M | $-13M | $162M | $186M | $137M | $45M | $93M | $-4M | $34M | $-2M | |
| Operating Cash Flow | $593M | $738M | $786M | $569M | $1.17B | $662M | $747M | $555M | $439M | $248M | $238M | $227M | |
| CapEx | $102M | $116M | $178M | $292M | $401M | $155M | $150M | $223M | $196M | $71M | $53M | $24M | |
| Investing Cash Flow | $-112M | $-255M | $-196M | $-213M | $-563M | $-232M | $-350M | $7M | $-251M | $73M | $-166M | $-202M | |
| Stock Issued | $22M | $25M | $27M | $26M | $26M | $20M | $18M | $17M | $14M | $14M | $11M | $18M | |
| Stock Repurchased | $466M | $353M | $592M | $435M | $375M | $0 | $400M | $300M | $104M | $96M | $102M | $98M | |
| Net Stock Activity | $-444M | $-328M | $-566M | $-409M | $-349M | $20M | $-382M | $-283M | $-89M | $-82M | $-90M | $-80M | |
| Financing Cash Flow | $-465M | $-356M | $-598M | $-502M | $-458M | $-31M | $-486M | $-369M | $-136M | $-96M | $-101M | $-66M | |
| Net Change in Cash | $51M | $106M | $-4M | $-158M | $139M | $410M | $-86M | $187M | $57M | $222M | $-32M | $-43M | |
| Taxes Paid | $135M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $491M | $623M | $608M | $277M | $771M | $507M | $598M | $331M | $243M | $177M | $185M | $203M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% | 75.7% | 75.9% | |
| Operating Margin | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% | 22.3% | 25.4% | |
| Net Margin | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% | 17.0% | 19.1% | |
| Pretax Margin | 14.5% | 15.2% | 16.6% | 16.0% | 25.6% | 15.3% | 23.4% | 23.7% | 24.8% | 22.5% | 22.0% | 25.0% | |
| EBITDA Margin | 19.4% | 18.8% | 20.3% | 20.6% | 27.5% | 19.4% | 25.8% | 26.5% | 26.6% | 25.3% | 24.4% | 27.8% | |
| ROA | 6.6% | 6.9% | 7.4% | 6.1% | 14.3% | 48.4% | 19.4% | 20.9% | 14.6% | 14.8% | 13.4% | 16.0% | |
| ROE | 10.3% | 10.8% | 12.0% | 9.9% | 21.6% | 56.7% | 33.4% | 32.7% | 21.5% | 20.6% | 18.0% | 21.0% | |
| ROIC | 9.4% | 10.9% | 12.3% | 10.8% | 20.5% | 56.1% | 32.2% | 32.6% | 19.8% | 19.7% | 17.2% | 19.7% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.7 | 1.9 | 2.3 | 2.7 | 2.7 | 3.3 | |
| Quick Ratio | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 | 1.2 | 1.5 | 1.7 | 2.1 | 2.5 | 2.5 | 2.9 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | |
| Inventory Turnover | 5.5 | 4.4 | 3.6 | 3.9 | 5.5 | 5.6 | 7.9 | 11.9 | 12.1 | 11.4 | 11.6 | 12.3 | |
| Receivables Turnover | 3.8 | 4.2 | 4.4 | 4.3 | 5.1 | 4.1 | 4.9 | 5.2 | 5.2 | 5.3 | 5.9 | 6.3 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $56.74 | $52.16 | $48.36 | $46.61 | $46.03 | $41.01 | $17.16 | $15.70 | $14.37 | $12.51 | $10.67 | $9.39 | |
| Revenue / Share | $55.59 | $53.33 | $50.44 | $47.62 | $49.61 | $31.20 | $30.05 | $24.17 | $18.01 | $13.25 | $10.37 | $9.26 | |
| Cash Flow / Share | $8.17 | $9.84 | $10.26 | $7.25 | $14.72 | $8.36 | $9.33 | $6.82 | $5.36 | $3.04 | $2.92 | $2.76 | |
| Cash / Share | $15.34 | $14.14 | $12.49 | $12.19 | $13.97 | $12.18 | $7.02 | $7.98 | $5.62 | $4.89 | $2.11 | $2.49 | |
| EPS (TTM) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.90% | 3.5% | 3.4% | -5.5% | 59.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.6% | 0.39% | 16.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 0.53% | -3.3% | 26.0% | -52.4% | -56.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 7.0% | -16.6% | -36.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -24.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -2.6% | -5.3% | 23.1% | -53.2% | -56.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 4.3% | -18.3% | -37.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -25.4% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Net Income TTM | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| Market Cap | $11.14B | $15.40B | $20.57B | $16.30B | $51.73B | $42.14B | $21.89B | $16.71B | $17.78B | $7.65B | $5.24B | $4.48B | |
| P/E | 27.6 | 37.1 | 47.2 | 45.7 | 67.8 | 23.8 | 50.5 | 42.6 | 78.5 | 41.3 | 37.2 | 31.6 | |
| P/S | 2.8 | 3.9 | 5.3 | 4.4 | 13.1 | 17.0 | 9.1 | 8.5 | 12.1 | 7.1 | 6.2 | 5.9 | |
| P/B | 2.8 | 4.0 | 5.7 | 4.5 | 14.3 | 13.0 | 16.3 | 13.3 | 15.5 | 7.7 | 6.2 | 6.0 | |
| P / Tangible Book | 3.2 | 4.7 | 6.6 | 5.3 | 16.7 | 15.8 | · | · | · | · | · | · | |
| P / Cash Flow | 18.8 | 20.9 | 26.2 | 28.7 | 44.1 | 63.6 | 29.3 | 30.1 | 40.6 | 30.9 | 22.0 | 19.8 | |
| P / FCF | 22.7 | 24.7 | 33.8 | 58.9 | 67.1 | 83.1 | 36.6 | 50.4 | 73.2 | 43.2 | 28.4 | 22.1 | |
| Earnings Yield | 3.6% | 2.7% | 2.1% | 2.2% | 1.5% | 4.2% | 2.0% | 2.4% | 1.3% | 2.4% | 2.7% | 3.2% |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.06B | $1.04B | $1.05B | $996M | $1.01B | $979M | $995M | $978M | $1.03B | $997M | $957M | $960M | $1.00B | $943M | $902M | $890M | |
| Cost of Revenue | $299M | $304M | $364M | $356M | $304M | $299M | $298M | $296M | $306M | $300M | $287M | $297M | $289M | $282M | $284M | $271M | |
| Gross Profit | $757M | $737M | $684M | $639M | $708M | $680M | $697M | $682M | $723M | $698M | $670M | $663M | $714M | $661M | $618M | $619M | |
| R&D Expense | $102M | $99M | $83M | $93M | $96M | $97M | $95M | $85M | $92M | $92M | $82M | $89M | $88M | $87M | $84M | $77M | |
| SG&A Expense | $463M | $465M | $442M | $418M | $449M | $448M | $425M | $434M | $452M | $452M | $403M | $408M | $453M | $440M | $410M | $399M | |
| Operating Expenses | $603M | $595M | $528M | $543M | $545M | $549M | $553M | $519M | $576M | $544M | $498M | $497M | $542M | $527M | $505M | $476M | |
| Operating Income | $154M | $142M | $155M | $96M | $163M | $131M | $144M | $162M | $147M | $154M | $172M | $166M | $172M | $134M | $113M | $144M | |
| Other Non-op | $-10M | $3M | $17M | $-5M | $8M | $4M | $-12M | $-371.0K | $-6M | $-141.0K | $-4M | $-10M | $-5M | $-1M | $-100.0K | $-23M | |
| Pretax Income | $149M | $149M | $177M | $95M | $174M | $140M | $141M | $166M | $144M | $158M | $173M | $162M | $172M | $135M | $115M | $123M | |
| Income Tax | $40M | $36M | $41M | $38M | $49M | $47M | $37M | $50M | $47M | $53M | $49M | $41M | $60M | $47M | $74M | $50M | |
| Net Income | $108M | $113M | $136M | $57M | $125M | $93M | $104M | $116M | $97M | $105M | $124M | $121M | $112M | $88M | $42M | $73M | |
| EPS (Basic) | $1.51 | $1.58 | $1.89 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.40 | $1.63 | $1.59 | $1.46 | $1.14 | $0.54 | $0.93 | |
| EPS (Diluted) | $1.51 | $1.57 | $1.88 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.39 | $1.63 | $1.58 | $1.46 | $1.14 | $0.54 | $0.93 | |
| Shares (Basic) | 71,495,000 | 71,425,000 | · | 72,377,000 | 72,565,000 | 73,562,000 | · | 74,736,000 | 75,184,000 | 75,175,000 | · | 76,569,000 | 76,524,000 | 76,921,000 | · | 78,093,000 | |
| Shares (Diluted) | 71,520,000 | 71,614,000 | · | 72,419,000 | 72,593,000 | 73,615,000 | · | 74,757,000 | 75,223,000 | 75,322,000 | · | 76,826,000 | 76,689,000 | 77,111,000 | · | 78,237,000 | |
| EBITDA | $194M | $199M | · | $152M | $204M | $170M | · | $200M | $183M | $187M | · | $203M | $208M | $169M | · | $176M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.06B | $1.09B | $1.00B | $901M | $873M | $1.04B | $1.04B | $761M | $866M | · | $1.24B | $952M | $832M | · | $1.04B | |
| Receivables | $1.15B | $1.13B | $1.10B | $1.10B | $1.12B | $1.06B | $996M | $1.01B | $1.02B | $951M | · | $904M | $908M | $884M | · | $860M | |
| Inventory | $212M | $215M | $226M | $228M | $244M | $247M | $254M | $254M | $259M | $280M | · | $296M | $313M | $312M | · | $321M | |
| Prepaid Expense | $200M | $216M | $166M | $174M | $187M | $220M | $199M | $291M | $351M | $350M | · | $218M | $237M | $252M | · | $229M | |
| Other Current Assets | $52M | $57M | $47M | $57M | $57M | $83M | $82M | $69M | $71M | $70M | · | $34M | $23M | $23M | · | $47M | |
| Current Assets | $2.66B | $2.66B | $2.62B | $2.53B | $2.45B | $2.40B | $2.49B | $2.60B | $2.41B | $2.48B | · | $2.70B | $2.47B | $2.33B | · | $2.50B | |
| PP&E (Net) | $1.11B | $1.11B | $1.13B | $1.18B | $1.26B | $1.26B | $1.27B | $1.29B | $1.28B | $1.28B | · | $1.27B | $1.28B | $1.26B | · | $1.20B | |
| PP&E (Gross) | · | · | $1.90B | · | · | · | $1.93B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $767M | · | · | · | $662M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $497M | $503M | $492M | $492M | $491M | $458M | $443M | $472M | $454M | $458M | $420M | $404M | $415M | $414M | $408M | $378M | |
| Intangibles | $95M | $101M | $94M | $99M | $103M | $103M | $103M | $116M | $116M | $121M | · | $83M | $89M | $93M | · | $92M | |
| Other Non-current Assets | $453M | $365M | $278M | $254M | $251M | $239M | $234M | $200M | $198M | $122M | · | $132M | $138M | $54M | · | $52M | |
| Total Assets | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Accounts Payable | $110M | $124M | $121M | $126M | $114M | $125M | $109M | $109M | $106M | $117M | · | $100M | $110M | $131M | · | $139M | |
| Accrued Liabilities | $612M | $547M | $537M | $546M | $563M | $546M | $598M | $575M | $555M | $497M | · | $614M | $600M | $497M | · | $384M | |
| Current Liabilities | $1.91B | $1.91B | $1.92B | $1.97B | $2.00B | $1.99B | $2.04B | $2.06B | $2.04B | $2.02B | · | $2.12B | $2.11B | $2.00B | · | $1.81B | |
| Capital Leases | $87M | $83M | $83M | $87M | $90M | $86M | $88M | $96M | $98M | $95M | · | $99M | $105M | $99M | · | $97M | |
| Other Non-current Liabilities | $120M | $108M | $114M | $112M | $117M | $131M | $140M | $150M | $158M | $156M | · | $179M | $181M | $191M | · | $185M | |
| Total Liabilities | $2.19B | $2.16B | $2.18B | $2.28B | $2.31B | $2.31B | $2.36B | $2.42B | $2.40B | $2.40B | · | $2.52B | $2.51B | $2.42B | · | $2.22B | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | · | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Paid-in Capital | $1.57B | $1.53B | $1.51B | $1.48B | $1.43B | $1.39B | $1.36B | $1.34B | $1.28B | $1.24B | · | $1.19B | $1.14B | $1.10B | · | $1.06B | |
| Retained Earnings | $2.60B | $2.55B | $2.46B | $2.42B | $2.43B | $2.39B | $2.48B | $2.57B | $2.46B | $2.50B | · | $2.61B | $2.49B | $2.37B | · | $2.67B | |
| AOCI | $67M | $70M | $75M | $65M | $61M | $18M | $6M | $36M | $25M | $18M | · | $2M | $11M | $2M | · | $-41M | |
| Stockholders' Equity | $4.23B | $4.15B | $4.05B | $3.96B | $3.91B | $3.79B | $3.85B | $3.94B | $3.76B | $3.76B | $3.63B | $3.80B | $3.64B | $3.48B | $3.60B | $3.69B | |
| Liabilities + Equity | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Shares Outstanding | 71,245,000 | 71,617,000 | 71,364,000 | 72,040,000 | 72,486,000 | 73,057,000 | 73,849,000 | 74,757,000 | 74,696,000 | 75,281,000 | · | 76,588,000 | 76,532,000 | 76,516,000 | · | 78,111,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $57M | $102M | $56M | $41M | $39M | $38M | $38M | $36M | $33M | $34M | $37M | $36M | $36M | $34M | $32M | |
| Stock-based Comp | $46M | $41M | $44M | $48M | $48M | $45M | $39M | $49M | $47M | $39M | $39M | $40M | $38M | $38M | $35M | $33M | |
| Deferred Tax | $-9M | $41M | $42M | $-9M | $-34M | $34M | $8M | $8M | $-9M | $18M | $4M | $14M | $-18M | $-18M | $-46M | $-8M | |
| Amort. of Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Restructuring | · | · | · | $32M | $-100.0K | $2M | $37M | $0 | $-357.0K | $14M | $14M | · | $100.0K | $10M | $10M | · | |
| Other Non-cash | · | $-100M | · | · | · | $-158M | · | · | · | $-166M | · | · | · | $57M | · | · | |
| Operating Cash Flow | $193M | $151M | $223M | $189M | $129M | $53M | $286M | $264M | $160M | $29M | $47M | $287M | $252M | $200M | $145M | $266M | |
| CapEx | $36M | $31M | $36M | $20M | $21M | $25M | $23M | $30M | $53M | $9M | $33M | $22M | $59M | $64M | $53M | $75M | |
| Investing Cash Flow | $-82M | $-132M | $-36M | $-20M | $-31M | $-25M | $-54M | $-9M | $-112M | $-80M | $-13M | $-4M | $-125M | $-53M | $-56M | $-85M | |
| Stock Issued | $0 | $12M | $0 | $8M | $0 | $14M | $0 | $11M | $0 | $14M | $0 | $12M | $0 | $14M | $0 | $11M | |
| Stock Repurchased | $67M | $31M | $97M | $72M | $96M | $201M | $203M | $0 | $150M | $0 | $300M | $0 | $0 | $292M | $160M | $0 | |
| Net Stock Activity | · | $-19M | · | · | · | $-187M | · | · | · | $14M | · | · | · | $-278M | · | · | |
| Financing Cash Flow | $-67M | $-48M | $-97M | $-64M | $-96M | $-207M | $-203M | $11M | $-152M | $-12M | $-350M | $12M | $-931.0K | $-259M | $-200M | $11M | |
| Net Change in Cash | $43M | $-35M | $90M | $103M | $28M | $-171M | $2M | $281M | $-104M | $-72M | $-301M | $287M | $120M | $-110M | $-102M | $167M | |
| Free Cash Flow | · | $120M | · | · | · | $27M | · | · | · | $19M | · | · | · | $136M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.7% | 70.8% | · | 64.2% | 69.9% | 69.5% | · | 69.7% | 70.3% | 70.0% | · | 69.1% | 71.2% | 70.0% | · | 69.5% | |
| Operating Margin | 14.6% | 13.7% | · | 9.7% | 16.1% | 13.4% | · | 16.6% | 14.3% | 15.4% | · | 17.3% | 17.2% | 14.2% | · | 16.1% | |
| Net Margin | 10.2% | 10.8% | · | 5.7% | 12.3% | 9.5% | · | 11.9% | 9.4% | 10.5% | · | 12.7% | 11.2% | 9.3% | · | 8.2% | |
| Pretax Margin | 14.1% | 14.3% | · | 9.5% | 17.1% | 14.3% | · | 17.0% | 14.0% | 15.9% | · | 16.9% | 17.1% | 14.3% | · | 13.8% | |
| EBITDA Margin | 18.4% | 19.1% | · | 15.3% | 20.1% | 17.4% | · | 20.5% | 17.8% | 18.8% | · | 21.2% | 20.7% | 17.9% | · | 19.8% | |
| ROA | 1.7% | 1.8% | · | 0.90% | 2.0% | 1.5% | · | 1.8% | 1.6% | 1.7% | · | 2.0% | 1.9% | 1.5% | · | 1.3% | |
| ROE | 2.7% | 2.8% | · | 1.4% | 3.2% | 2.5% | · | 3.0% | 2.6% | 2.9% | · | 3.2% | 3.1% | 2.5% | · | 2.0% | |
| ROIC | 2.6% | 2.6% | · | 1.5% | 3.0% | 2.3% | · | 2.9% | 2.6% | 2.7% | · | 3.3% | 3.1% | 2.5% | · | 2.3% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 0.9 | 0.9 | · | 1.0 | 0.9 | 0.9 | · | 1.1 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.3 | 1.3 | · | 1.5 | 1.2 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 | 0.9 | 1.0 | · | 1.0 | |
| Receivables Turnover | 0.9 | 1.0 | · | 0.9 | 0.9 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $59.41 | $57.94 | · | $54.93 | $53.98 | $51.94 | · | $52.76 | $50.31 | $49.94 | · | $49.64 | $47.54 | $45.48 | · | $47.30 | |
| Revenue / Share | $14.77 | $14.52 | · | $13.75 | $13.95 | $13.30 | · | $13.08 | $13.67 | $13.24 | · | $12.50 | $13.07 | $12.23 | · | $11.38 | |
| Cash Flow / Share | · | $2.11 | · | · | · | $0.72 | · | · | · | $0.38 | · | · | · | $2.59 | · | · | |
| Cash / Share | $15.48 | $14.80 | · | $13.94 | $12.43 | $11.95 | · | $13.94 | $10.19 | $11.50 | · | $16.18 | $12.44 | $10.88 | · | $13.37 | |
| EPS (TTM) | $5.74 | $5.95 | · | $5.17 | $5.94 | $5.50 | · | $5.85 | $5.88 | $6.06 | · | $4.72 | $4.07 | $4.05 | · | $6.46 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.14B | $4.10B | · | $3.98B | $3.96B | $3.98B | · | $3.96B | $3.94B | $3.92B | · | $3.81B | $3.74B | $3.70B | · | $3.86B | |
| Net Income TTM | $414M | $430M | · | $378M | $438M | $410M | · | $442M | $447M | $462M | · | $363M | $314M | $315M | · | $511M | |
| Market Cap | $12.02B | $12.28B | · | $9.02B | $13.72B | $11.61B | · | $19.01B | $18.03B | $24.69B | · | $23.38B | $27.06B | $25.57B | · | $16.18B | |
| P/E | 29.4 | 28.8 | · | 24.2 | 31.9 | 28.9 | · | 43.5 | 41.1 | 54.1 | · | 64.7 | 86.9 | 82.5 | · | 32.1 | |
| P/S | 2.9 | 3.0 | · | 2.3 | 3.5 | 2.9 | · | 4.8 | 4.6 | 6.3 | · | 6.1 | 7.2 | 6.9 | · | 4.2 | |
| P/B | 2.8 | 3.0 | · | 2.3 | 3.5 | 3.1 | · | 4.8 | 4.8 | 6.6 | · | 6.2 | 7.4 | 7.3 | · | 4.4 | |
| P / Tangible Book | 3.3 | 3.5 | · | 2.7 | 4.1 | 3.6 | · | 5.7 | 5.7 | 7.8 | · | 7.1 | 8.6 | 8.6 | · | 5.0 | |
| P / Cash Flow | · | 81.3 | · | · | · | 220.3 | · | · | · | 861.2 | · | · | · | 127.9 | · | · | |
| Earnings Yield | 3.4% | 3.5% | · | 4.1% | 3.1% | 3.5% | · | 2.3% | 2.4% | 1.8% | · | 1.6% | 1.1% | 1.2% | · | 3.1% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B |
| Margem Bruta % | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% |
| Margem Operacional % | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% |
| Lucro líquido | $410M | $421M | $445M | $362M | $772M |
| EPS Diluído | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 |
| Índice de Liquidez Seca | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $491M | $623M | $608M | $277M | $771M |
Investidores institucionais (13F) 750 declarantes · $13.7B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
750
Valor detido
$13.7B
Novas posições
72
Posições encerradas
81
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 72 (-73 vs trimestre anterior) | 81 (-2 vs trimestre anterior) | 215 (-34 vs trimestre anterior) | 289 (+61 vs trimestre anterior) | +3.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.277.272.490 | 8.179.779 | 9,31% | Ações |
| BlackRock, Inc. | $745.370.304 | 4.419.366 | 5,44% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $742.325.451 | 4.401.313 | 5,41% | Ações |
| FMR LLC | $684.765.036 | 4.060.032 | 4,99% | Ações |
| Capital International Investors | $682.324.318 | 4.045.561 | 4,98% | Ações |
| Capital World Investors | $577.219.454 | 3.422.385 | 4,21% | Ações |
| GOLDMAN SACHS GROUP INC | $568.849.702 | 3.372.760 | 4,15% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $528.203.316 | 3.131.764 | 3,85% | Ações |
| STATE STREET CORP | $431.518.634 | 2.558.512 | 3,15% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $378.153.032 | 2.245.315 | 2,76% | Ações |
| Ninety One UK Ltd | $372.703.280 | 2.209.791 | 2,72% | Ações |
| UBS Group AG | $358.450.738 | 2.125.286 | 2,61% | Ações |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $292.369.455 | 1.733.484 | 2,13% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $242.715.391 | 1.438.900 | 1,77% | Ações |
| Invesco Ltd. | $238.412.210 | 1.413.567 | 1,74% | Ações |
| Ruane, Cunniff & Goldfarb L.P. | $197.577.600 | 1.171.455 | 1,44% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $180.736.225 | 1.071.601 | 1,32% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $180.291.468 | 1.068.964 | 1,31% | Ações |
| MORGAN STANLEY | $170.994.867 | 1.013.842 | 1,25% | Ações |
| NORGES BANK | $152.573.715 | 904.623 | 1,11% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $151.163.848 | 899.731 | 1,10% | Ações |
| JPMORGAN CHASE & CO | $134.654.324 | 773.182 | 0,98% | Ações |
| DISCIPLINED GROWTH INVESTORS INC /MN | $132.090.801 | 783.178 | 0,96% | Ações |
| Senvest Management, LLC | $125.709.888 | 745.345 | 0,92% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $112.686.638 | 668.129 | 0,82% | Ações |
| Swedbank AB | $111.012.012 | 658.200 | 0,81% | Ações |
| BARCLAYS PLC | $108.101.615 | 640.944 | 0,79% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $107.285.353 | 625.826 | 0,78% | Ações |
| Assenagon Asset Management S.A. | $106.450.265 | 631.153 | 0,78% | Ações |
| VOYA INVESTMENT MANAGEMENT LLC | $105.404.604 | 624.952 | 0,77% | Ações |
| DEUTSCHE BANK AG\ | $99.778.582 | 591.596 | 0,73% | Ações |
| NORTHERN TRUST CORP | $94.827.567 | 562.241 | 0,69% | Ações |
| BANK OF AMERICA CORP /DE/ | $93.085.478 | 551.912 | 0,68% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79.759.314 | 472.900 | 0,58% | Opção de venda |
| FEDERATED HERMES, INC. | $78.222.317 | 463.787 | 0,57% | Ações |
| Bares Capital Management, Inc. | $76.349.389 | 609.722 | 0,56% | Ações |
| Amundi | $73.309.080 | 434.656 | 0,53% | Ações |
| BROWN ADVISORY INC | $69.759.715 | 413.611 | 0,51% | Ações |
| DAVENPORT & Co LLC | $64.891.092 | 384.745 | 0,47% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $63.304.170 | 375.336 | 0,46% | Ações |
| JENNISON ASSOCIATES LLC | $59.641.380 | 353.619 | 0,43% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $59.357.000 | 351.934 | 0,43% | Ações |
| Bank of New York Mellon Corp | $57.062.230 | 338.327 | 0,42% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $56.163.780 | 333.000 | 0,41% | Opção de compra |
| Carmignac Gestion | $53.495.676 | 316.832 | 0,39% | Ações |
| CITADEL ADVISORS LLC | $50.443.170 | 299.082 | 0,37% | Ações |
| Resona Asset Management Co.,Ltd. | $49.583.874 | 291.177 | 0,36% | Ações |
| KEYBANK NATIONAL ASSOCIATION/OH | $47.572.414 | 282.061 | 0,35% | Ações |
| WELLS FARGO & COMPANY/MN | $47.249.188 | 280.145 | 0,34% | Ações |
| Nearwater Capital Markets, Ltd | $45.200.880 | 268.000 | 0,33% | Ações |
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Danaher Corporation ×3 declarações | 14 de Novembro de 2013 | · | Declaração inicial | Investimento passivo | SEC |
| 1. Danaher Corporation | 22 de Fevereiro de 2011 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 66 insiders · 24 diretores · 17 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Joseph M Hogan | President and CEO | 20 de Fevereiro de 2026 M | 209.270 | 0 | 0 | $0 |
| John Morici | EVP, CHIEF FINANCIAL OFFICER | 20 de Fevereiro de 2026 M | 13.536 | 0 | 1 | $-1.508.611 |
| Kenneth Arola | VP, Finance and CFO | 20 de Fevereiro de 2013 C | 31.682 | 0 | 0 | $0 |
| Julie Ann Coletti | EVP, CHIEF LEGAL & REGULATORY | 20 de Fevereiro de 2026 M | 11.445 | 0 | 0 | $0 |
| Stuart A Hockridge | EVP, GLOBAL HR | 20 de Fevereiro de 2026 M | 14.892 | 0 | 0 | $0 |
| Emory Wright | EVP, GLOBAL OPERATIONS | 20 de Fevereiro de 2024 A | 8.294 | 0 | 0 | $0 |
| Jennifer Olson | SVP & Mng Dir Cust Service | 6 de Novembro de 2020 G | 2.277 | 0 | 0 | $0 |
| Yuval Shaked | SVP & Mng Dir. Itero | 4 de Novembro de 2020 S | 636 | 0 | 0 | $0 |
| Zelko Relic | SVp, R&D and CTO | 4 de Novembro de 2020 S | 13.716 | 0 | 0 | $0 |
| Markus Christof Sebstian | SVP & Mng Dir EMEA | 20 de Outubro de 2020 M | 613 | 0 | 0 | $0 |
| Simon Beard | SVP and Mgng Director, EMEA | 27 de Agosto de 2020 S | 17.670 | 0 | 0 | $0 |
| Vamsi Mohan Raj Pudipeddi | SVP, Chief Marketing Officer | 18 de Maio de 2020 S | 0 | 0 | 0 | $0 |
| Sreelakshmi Kolli | SVP & Mng Dir Info Tech | 20 de Fevereiro de 2020 M | 13.409 | 0 | 0 | $0 |
| Raphael Pascaud | CMO & Bus. Dev. | 1 de Outubro de 2019 M | 27.156 | 0 | 0 | $0 |
| Julie Tay | SVP & Mng Dir. Asia Pacific | 8 de Maio de 2019 S | 17.746 | 0 | 0 | $0 |
| Christopher C. Puco | VP, No. American Sales | 30 de Novembro de 2018 S | 0 | 0 | 0 | $0 |
| Lynn Pendergrass | VP, Americas | 20 de Março de 2017 A | · | 0 | 0 | $0 |
| Timothy A Mack | VP, Bus Dev | 20 de Fevereiro de 2016 M | 0 | 0 | 0 | $0 |
| Jennifer Erfurth | VP, Global HR | 20 de Fevereiro de 2016 A | 10.760 | 0 | 0 | $0 |
| John Patrick Graham | VP, Mktg & CMO | 5 de Maio de 2015 S | 0 | 0 | 0 | $0 |
| Richard M.L. Twomey | VP International | 30 de Outubro de 2013 M | 4.272 | 0 | 0 | $0 |
| Dana Cambra | VP, R&D | 18 de Junho de 2012 C | 4.398 | 0 | 0 | $0 |
| Sheila K Tan | VP Marketing & CMO | 17 de Novembro de 2011 C | 19.523 | 0 | 0 | $0 |
| Afsaneh Azadeh | Chief Information Officer | 20 de Fevereiro de 2008 A | · | 0 | 0 | $0 |
| Quentin S. Blackford | Conselheiro | 27 de Agosto de 2026 A | · | 0 | 0 | $0 |
| Anne Myong | Conselheiro | 20 de Maio de 2026 A | 9.830 | 0 | 0 | $0 |
| Mojdeh Poul | Conselheiro | 20 de Maio de 2026 A | 3.553 | 0 | 0 | $0 |
| Kevin J Dallas | Conselheiro | 20 de Maio de 2026 A | 16.168 | 0 | 0 | $0 |
| Britt J. Vitalone | Conselheiro | 20 de Maio de 2026 A | 1.443 | 0 | 0 | $0 |
| Andrea Lynn Saia | Conselheiro | 20 de Maio de 2026 A | 17.318 | 0 | 0 | $0 |
| Kevin T Conroy | Conselheiro | 20 de Maio de 2026 A | 3.553 | 0 | 0 | $0 |
| Susan E Siegel | Conselheiro | 20 de Maio de 2026 A | 10.723 | 0 | 0 | $0 |
| Joseph Lacob | Conselheiro | 20 de Maio de 2026 A | 135.916 | 0 | 0 | $0 |
| MORROW GEORGE J | Conselheiro | 20 de Maio de 2026 M | 5.036 | 0 | 0 | $0 |
| Raymond C Larkin JR | Conselheiro | 20 de Maio de 2026 A | 27.454 | 0 | 0 | $0 |
| Warren S Thaler | Conselheiro | 17 de Maio de 2023 M | 31.780 | 0 | 0 | $0 |
| Greg J Santora | Conselheiro | 17 de Maio de 2023 M | 11.987 | 0 | 0 | $0 |
| Thomas M Prescott | Conselheiro | 19 de Maio de 2021 M | 54.129 | 0 | 0 | $0 |
| David E Collins | Conselheiro | 15 de Maio de 2014 C | 25.900 | 0 | 0 | $0 |
| Brian H Dovey | Conselheiro | 19 de Maio de 2004 A | 0 | 0 | 0 | $0 |
| DANAHER CORP /DE/ | Detentor de 10% | 13 de Novembro de 2013 S | 3.837.132 | 0 | 0 | $0 |
| KLEINER PERKINS CAUFIELD & BYERS VIII LP | Detentor de 10% | 10 de Novembro de 2004 J | 1.492.421 | 0 | 0 | $0 |
| Roger E George | · | 14 de Maio de 2019 S | 11.773 | 0 | 0 | $0 |
| David L White | · | 18 de Novembro de 2016 G | 5.913 | 0 | 0 | $0 |
| David C Nagel | · | 13 de Maio de 2016 M | 30.200 | 0 | 0 | $0 |
| Len Hedge | · | 20 de Fevereiro de 2013 C | 55.861 | 0 | 0 | $0 |
| Dan Scott Ellis | · | 19 de Novembro de 2012 M | 3.552 | 0 | 0 | $0 |
| Gil Laks | · | 24 de Fevereiro de 2010 C | 9.773 | 0 | 0 | $0 |
| Sonia Clark | · | 25 de Setembro de 2008 C | 1.806 | 0 | 0 | $0 |
| Darrell Zoromski | · | 20 de Agosto de 2008 C | 1.647 | 0 | 0 | $0 |
| Kent H Bowen | · | 15 de Maio de 2008 C | 84.500 | 0 | 0 | $0 |
| Hossein Arjomand | · | 26 de Novembro de 2007 C | 617 | 0 | 0 | $0 |
| Eldon M Bullington | · | 26 de Novembro de 2007 C | 4.967 | 0 | 0 | $0 |
| Michael J Henry | · | 1 de Maio de 2007 S | 0 | 0 | 0 | $0 |
| Kelsey Wirth | · | 2 de Maio de 2006 S | 1.074.022 | 0 | 0 | $0 |
| David Thrower | · | 10 de Agosto de 2005 M | 15.980 | 0 | 0 | $0 |
| Brian Dovey | · | 25 de Maio de 2005 A | · | 0 | 0 | $0 |
| Rok Sribar | · | 1 de Março de 2005 A | · | 0 | 0 | $0 |
| Robert D Mitchell | · | 22 de Fevereiro de 2005 A | · | 0 | 0 | $0 |
| Patricia L Wadors | · | 22 de Fevereiro de 2005 A | · | 0 | 0 | $0 |
| Cecilia Claudio | · | 22 de Fevereiro de 2005 A | · | 0 | 0 | $0 |
| KPCB VIII ASSOCIATES LP | · | 10 de Novembro de 2004 J | 86.526 | 0 | 0 | $0 |
| Amir Abolfathi | · | 8 de Novembro de 2004 M | 10.334 | 0 | 0 | $0 |
| Jon Fjeld | · | 28 de Maio de 2004 S | 108.864 | 0 | 0 | $0 |
| Gordon Gund | · | 10 de Maio de 2004 P | 68.659 | 0 | 0 | $0 |
| Joe Breeland | · | 12 de Março de 2004 A | 53.985 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 84 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 3,44% | 9.273 NS | 31 de Julho de 2026 | N-PORT |
| PRNT · ARK ETF Trust | 1,58% | 5.467 NS | 31 de Julho de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 94.083 SH | 2 de Outubro de 2026 | Diário |
| RNIN · EA Series Trust | 1,09% | 11.732 NS | 31 de Julho de 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 0,90% | 4.911 NS | 31 de Julho de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,85% | 52.527 NS | 31 de Julho de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,70% | 376 NS | 31 de Julho de 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0,62% | 41.430 SH | 2 de Outubro de 2026 | Diário |
| HIBL · Direxion Shares ETF Trust | 0,61% | 2.712 NS | 31 de Julho de 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,52% | 6.492 NS | 31 de Julho de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,48% | 751 SH | 2 de Outubro de 2026 | Diário |
| BKMC · BNY Mellon ETF Trust | 0,28% | 10.766 NS | 31 de Julho de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,28% | 235.486 NS | 31 de Julho de 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 30.473 NS | 31 de Julho de 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,24% | 990.688 SH | 19 de Agosto de 2026 | Diário |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 1.276.314 SH | 2 de Outubro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,17% | 204.512 SH | 19 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 32.382 NS | 31 de Julho de 2026 | N-PORT |
| IYH · iShares Trust | 0,16% | 39.100 SH | 11 de Setembro de 2026 | Diário |
| ISCG · iShares Trust | 0,15% | 9.672 SH | 11 de Setembro de 2026 | Diário |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,15% | 12.214 NS | 31 de Julho de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,15% | 133.009 NS | 31 de Julho de 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,15% | 2.860 NS | 31 de Julho de 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 1.921 NS | 31 de Julho de 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1.560.504 SH | 19 de Agosto de 2026 | Diário |
| VFQY · VANGUARD WELLINGTON FUND | 0,14% | 4.009 SH | 19 de Agosto de 2026 | Diário |
| ESML · iShares Trust | 0,14% | 25.829 SH | 11 de Setembro de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,13% | 1.311 NS | 31 de Julho de 2026 | N-PORT |
| IXJ · iShares Trust | 0,13% | 34.914 SH | 11 de Setembro de 2026 | Diário |
| IWS · iShares Trust | 0,10% | 100.293 SH | 11 de Setembro de 2026 | Diário |
| PEXL · Pacer Funds Trust | 0,10% | 295 NS | 31 de Julho de 2026 | N-PORT |
| WSML · iShares Trust | 0,10% | 4.205 SH | 11 de Setembro de 2026 | Diário |
| RECS · Columbia ETF Trust I | 0,09% | 32.471 NS | 31 de Julho de 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 5.016 SH | 2 de Outubro de 2026 | Diário |
| VFVA · VANGUARD WELLINGTON FUND | 0,09% | 4.336 SH | 19 de Agosto de 2026 | Diário |
| VFMF · VANGUARD WELLINGTON FUND | 0,08% | 3.482 SH | 19 de Agosto de 2026 | Diário |
| IWR · iShares Trust | 0,07% | 274.791 SH | 11 de Setembro de 2026 | Diário |
| XOEF · iShares Trust | 0,06% | 83 SH | 11 de Setembro de 2026 | Diário |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,04% | 424 NS | 31 de Julho de 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 15.374 SH | 19 de Agosto de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,04% | 1.211 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 4.965 NS | 31 de Julho de 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,03% | 417 NS | 31 de Julho de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 96.570 NS | 31 de Julho de 2026 | N-PORT |
| IVE · iShares Trust | 0,03% | 111.147 SH | 11 de Setembro de 2026 | Diário |
| IUSV · iShares Trust | 0,03% | 57.946 SH | 11 de Setembro de 2026 | Diário |
| DFUV · Dimensional ETF Trust | 0,03% | 27.760 NS | 31 de Julho de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 20.398 SH | 2 de Outubro de 2026 | Diário |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 40.343 SH | 19 de Agosto de 2026 | Diário |
| DCOR · Dimensional ETF Trust | 0,03% | 5.902 NS | 31 de Julho de 2026 | N-PORT |
| DSI · iShares Trust | 0,03% | 10.314 SH | 11 de Setembro de 2026 | Diário |
| IWD · iShares Trust | 0,03% | 148.444 SH | 11 de Setembro de 2026 | Diário |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 1.793 SH | 2 de Outubro de 2026 | Diário |
| TILT · FlexShares Trust | 0,03% | 3.318 NS | 31 de Julho de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,02% | 7.096 SH | 2 de Outubro de 2026 | Diário |
| DFAU · Dimensional ETF Trust | 0,02% | 15.866 NS | 31 de Julho de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 13.476 SH | 2 de Outubro de 2026 | Diário |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 1.729.431 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 2.161.771 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 10.952 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 5.657 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,02% | 15.119 SH | 19 de Agosto de 2026 | Diário |
| TOPC · iShares Trust | 0,02% | 40 SH | 11 de Setembro de 2026 | Diário |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,02% | 2.055 SH | 2 de Outubro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,02% | 21.777 NS | 31 de Julho de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 3.372 NS | 31 de Julho de 2026 | N-PORT |
| XVV · iShares Trust | 0,02% | 762 SH | 11 de Setembro de 2026 | Diário |
| SPUU · Direxion Shares ETF Trust | 0,02% | 251 NS | 31 de Julho de 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,02% | 1.595 NS | 31 de Julho de 2026 | N-PORT |
| IVV · iShares Trust | 0,02% | 839.331 SH | 11 de Setembro de 2026 | Diário |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 393 SH | 2 de Outubro de 2026 | Diário |
| IWB · iShares Trust | 0,01% | 46.084 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,01% | 18.798 SH | 11 de Setembro de 2026 | Diário |
| IYY · iShares Trust | 0,01% | 2.819 SH | 11 de Setembro de 2026 | Diário |
| HCMT · Direxion Shares ETF Trust | 0,01% | 464 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 87.429 SH | 11 de Setembro de 2026 | Diário |
| SPXL · Direxion Shares ETF Trust | 0,01% | 5.207 NS | 31 de Julho de 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 53 SH | 1 de Outubro de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 58.076 SH | 19 de Agosto de 2026 | Diário |
| LGDX · Tidal Trust III | 0,01% | 71 NS | 31 de Julho de 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0,16% | -24.215 NS | 31 de Julho de 2026 | N-PORT |
| SLTY · Tidal Trust II | -2,76% | -3.000 NS | 31 de Julho de 2026 | N-PORT |
| ISCB · iShares Trust | · | 3.130 SH | 11 de Setembro de 2026 | Diário |
| ISCV · iShares Trust | · | 8.638 SH | 11 de Setembro de 2026 | Diário |
ALGN Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 25 analistas
COMPRA
Alvo mediano
$207.00
+44,0%
7 28,0%
Compra forte
9 36,0%
Compra
8 32,0%
Manter
1 4,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
14 analistas · 2026-10-02Alvo médio $206.36 +43,6%
← Abaixo de todos os alvos
Preço atual $143.74
Mín$170.00
Média$206.36
Máx$235.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
Últimas notícias Notícias recentes mencionando esta empresa
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
BLUECHIP_DIP
Stop out
risco 1
recompensa 2,08
entrada
$167.85
R:R 2,08
BLUECHIP_DIP
Stop out
risco 1
recompensa 1,79
entrada
$171.75
R:R 1,79
BLUECHIP_DIP
Stop out
risco 1
recompensa 1,85
entrada
$173.53
R:R 1,85
RANGE
Expirado
risco 1
recompensa 5,00
entrada
$167.23
R:R 5,00
Nenhum sinal aberto no momento — nenhum cartão está preenchido, e isso é honesto.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 5, 2026